NCT02194491View on ClinicalTrials.gov

A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Pharmacokinetics of ASP3662Displacement of RadiotracerHealthy Volunteers

Interventions

OTHER

[11C]AS2471907

intravenous radiotracer

RADIATION

Positron Emission Tomography (PET)

Imaging scanning procedure

DRUG

ASP3662

oral

Trial Locations (1)

06520-8-48

Site US10001, New Haven

All Listed Sponsors

collaborator

Yale University

OTHER

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02194491 - A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662 | Biotech Hunter | Biotech Hunter